alphaveSUVEN₹360.00

Suven Life Sciences Limited

₹ CrorePeersVIMTALABS TAKEMcap ₹9,494 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	27.5	59.5	55.7	55.7
+ Capital Work-in-Progress	0.0	0.0	3.6	3.6
+ Other Intangibles	0.2	0.2	0.1	0.1
+ Other Non-current Financial Assets	0.0	0.0	18.0	18.0
Non-current Financial Assets	0.0	0.0	18.0	18.0
+ Other Non-current Assets	0.5	—	0.0	0.0
Total Non-current Assets	28.2	59.7	77.5	77.5
Current Assets
+ Inventories	0.7	0.2	0.1	0.1
+ Current Investments	75.9	22.3	0.0	0.0
+ Trade Receivables	1.3	1.3	1.5	1.5
+ Cash & Cash Equivalents	14.9	15.0	8.3	8.3
+ Other Bank Balances	149.0	22.7	329.2	329.2
+ Other Current Financial Assets	2.2	0.1	184.4	184.4
Current Financial Assets	243.4	61.4	523.3	523.3
+ Other Current Assets	10.8	12.6	21.3	21.3
Total Current Assets	256.7	75.5	546.7	546.7
Total Assets	284.9	135.2	624.2	624.2
Equity
+ Equity Share Capital	21.8	21.8	26.4	26.4
+ Other Equity / Reserves	248.2	88.2	565.0	565.0
Equity — Owners of Parent	270.0	110.0	591.4	591.4
Total Equity	270.0	110.0	591.4	591.4
Liabilities
+ Provisions — Non-current	1.3	1.7	1.9	1.9
Non-current Liabilities	1.3	1.7	1.9	1.9
+ Trade Payables	2.1	5.2	4.8	4.8
+ Other Current Financial Liab	9.8	0.6	22.3	22.3
Current Financial Liabilities	11.9	5.8	27.1	27.1
+ Provisions — Current	1.1	1.6	1.5	1.5
+ Other Current Liabilities	0.5	16.0	2.2	2.2
Current Liabilities	13.5	23.5	30.9	30.9
Total Liabilities	14.9	25.2	32.8	32.8
Total Equity & Liabilities	284.9	135.2	624.2	624.2
Assets — additional as-filed lines
+ Current Tax Assets	1.8	1.2	1.9	1.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.4	0.4	0.4
+ Dues to Other Creditors — Current	—	4.8	4.4	4.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.